Express News | NYSE Order Imbalance 129390.0 Shares on Buy Side

BreakingsMay 30 14:50

Teva Pharmaceuticals Is Maintained at Buy by B of A Securities

Teva Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow JonesMay 30 10:55

Teva Pharmaceutical Indus Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 27.12% B of A Securities $18 → $21 Maintains Buy 05/13/2024 21.07% Piper Sandler $19 → $20 Reit

BenzingaMay 30 10:44

Teva Wins FDA Nod for New Austedo Formulation

Seeking AlphaMay 30 06:33

Express News | Teva : BofA Global Research Raises Price Objective to $21 From $18

BreakingsMay 30 06:11

Reported Earlier, Teva's AUSTEDO XR Receives FDA Green Light, One Pill, Once-Daily Dosage Now Available For TD And HD Chorea

U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day)AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 (VMAT2)

BenzingaMay 30 02:16